 | • レポートコード：MRC2312MG06869 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、74ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のラコサミド注射液市場規模と予測を収録しています。・世界のラコサミド注射液市場：売上、2018年-2023年、2024年-2029年 ・世界のラコサミド注射液市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のラコサミド注射液市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ジェネリック医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ラコサミド注射液のグローバル主要企業は、Shijiazhuang No.4 Pharmaceutical Co., Ltd.、 Chengdu Lier Pharmaceutical Co., Ltd.、 Hefei Yifan Biopharmaceuticals Inc.、 Jiangsu Haian Pharmaceutical Co., Ltd.、 Jiangxi Kerui Pharmaceutical Co., Ltd.、 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.、 UCB Pharma Limited、 Camber Pharmaceuticals、 Fresenius Kabiなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ラコサミド注射液のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のラコサミド注射液市場：タイプ別、2018年-2023年、2024年-2029年 世界のラコサミド注射液市場：タイプ別市場シェア、2022年 ・ジェネリック医薬品、先発医薬品 世界のラコサミド注射液市場：用途別、2018年-2023年、2024年-2029年 世界のラコサミド注射液市場：用途別市場シェア、2022年 ・病院、ドラッグストア、ネット販売、その他 世界のラコサミド注射液市場：地域・国別、2018年-2023年、2024年-2029年 世界のラコサミド注射液市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるラコサミド注射液のグローバル売上、2018年-2023年 ・主要企業におけるラコサミド注射液のグローバル売上シェア、2022年 ・主要企業におけるラコサミド注射液のグローバル販売量、2018年-2023年 ・主要企業におけるラコサミド注射液のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Shijiazhuang No.4 Pharmaceutical Co., Ltd.、 Chengdu Lier Pharmaceutical Co., Ltd.、 Hefei Yifan Biopharmaceuticals Inc.、 Jiangsu Haian Pharmaceutical Co., Ltd.、 Jiangxi Kerui Pharmaceutical Co., Ltd.、 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.、 UCB Pharma Limited、 Camber Pharmaceuticals、 Fresenius Kabi ************************************************************* ・調査・分析レポートの概要 ラコサミド注射液市場の定義 市場セグメント 世界のラコサミド注射液市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のラコサミド注射液市場規模 世界のラコサミド注射液市場規模：2022年 VS 2029年 世界のラコサミド注射液市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのラコサミド注射液の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のラコサミド注射液製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ジェネリック医薬品、先発医薬品 ラコサミド注射液のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、ドラッグストア、ネット販売、その他 ラコサミド注射液の用途別グローバル売上・予測 ・地域別市場分析 地域別ラコサミド注射液市場規模 2022年と2029年 地域別ラコサミド注射液売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Shijiazhuang No.4 Pharmaceutical Co., Ltd.、 Chengdu Lier Pharmaceutical Co., Ltd.、 Hefei Yifan Biopharmaceuticals Inc.、 Jiangsu Haian Pharmaceutical Co., Ltd.、 Jiangxi Kerui Pharmaceutical Co., Ltd.、 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.、 UCB Pharma Limited、 Camber Pharmaceuticals、 Fresenius Kabi ... |
This research report provides a comprehensive analysis of the Lacosamide Injection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Lacosamide Injection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Lacosamide Injection, challenges faced by the industry, and potential opportunities for market players.
The global Lacosamide Injection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Lacosamide Injection market presents opportunities for various stakeholders, including Hospital, Retail Drug Store. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Lacosamide Injection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Lacosamide Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Lacosamide Injection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Lacosamide Injection market.
Market Overview: The report provides a comprehensive overview of the Lacosamide Injection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Generic Drug, Original Drug), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Lacosamide Injection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Lacosamide Injection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Lacosamide Injection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Lacosamide Injection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Lacosamide Injection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Lacosamide Injection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Lacosamide Injection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Lacosamide Injection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Lacosamide Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Generic Drug
Original Drug
Market segment by Application
Hospital
Retail Drug Store
Online Sales
Others
Global Lacosamide Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Chengdu Lier Pharmaceutical Co., Ltd.
Hefei Yifan Biopharmaceuticals Inc.
Jiangsu Haian Pharmaceutical Co., Ltd.
Jiangxi Kerui Pharmaceutical Co., Ltd.
Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
UCB Pharma Limited
Camber Pharmaceuticals
Fresenius Kabi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lacosamide Injection, market overview.
Chapter 2: Global Lacosamide Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Lacosamide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lacosamide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Lacosamide Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Lacosamide Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lacosamide Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lacosamide Injection Overall Market Size
2.1 Global Lacosamide Injection Market Size: 2022 VS 2029
2.2 Global Lacosamide Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Lacosamide Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Lacosamide Injection Players in Global Market
3.2 Top Global Lacosamide Injection Companies Ranked by Revenue
3.3 Global Lacosamide Injection Revenue by Companies
3.4 Global Lacosamide Injection Sales by Companies
3.5 Global Lacosamide Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Lacosamide Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Lacosamide Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lacosamide Injection Players in Global Market
3.8.1 List of Global Tier 1 Lacosamide Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Lacosamide Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Lacosamide Injection Market Size Markets, 2022 & 2029
4.1.2 Generic Drug
4.1.3 Original Drug
4.2 By Type – Global Lacosamide Injection Revenue & Forecasts
4.2.1 By Type – Global Lacosamide Injection Revenue, 2018-2023
4.2.2 By Type – Global Lacosamide Injection Revenue, 2024-2029
4.2.3 By Type – Global Lacosamide Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Lacosamide Injection Sales & Forecasts
4.3.1 By Type – Global Lacosamide Injection Sales, 2018-2023
4.3.2 By Type – Global Lacosamide Injection Sales, 2024-2029
4.3.3 By Type – Global Lacosamide Injection Sales Market Share, 2018-2029
4.4 By Type – Global Lacosamide Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Lacosamide Injection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Drug Store
5.1.4 Online Sales
5.1.5 Others
5.2 By Application – Global Lacosamide Injection Revenue & Forecasts
5.2.1 By Application – Global Lacosamide Injection Revenue, 2018-2023
5.2.2 By Application – Global Lacosamide Injection Revenue, 2024-2029
5.2.3 By Application – Global Lacosamide Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Lacosamide Injection Sales & Forecasts
5.3.1 By Application – Global Lacosamide Injection Sales, 2018-2023
5.3.2 By Application – Global Lacosamide Injection Sales, 2024-2029
5.3.3 By Application – Global Lacosamide Injection Sales Market Share, 2018-2029
5.4 By Application – Global Lacosamide Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Lacosamide Injection Market Size, 2022 & 2029
6.2 By Region – Global Lacosamide Injection Revenue & Forecasts
6.2.1 By Region – Global Lacosamide Injection Revenue, 2018-2023
6.2.2 By Region – Global Lacosamide Injection Revenue, 2024-2029
6.2.3 By Region – Global Lacosamide Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Lacosamide Injection Sales & Forecasts
6.3.1 By Region – Global Lacosamide Injection Sales, 2018-2023
6.3.2 By Region – Global Lacosamide Injection Sales, 2024-2029
6.3.3 By Region – Global Lacosamide Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Lacosamide Injection Revenue, 2018-2029
6.4.2 By Country – North America Lacosamide Injection Sales, 2018-2029
6.4.3 US Lacosamide Injection Market Size, 2018-2029
6.4.4 Canada Lacosamide Injection Market Size, 2018-2029
6.4.5 Mexico Lacosamide Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Lacosamide Injection Revenue, 2018-2029
6.5.2 By Country – Europe Lacosamide Injection Sales, 2018-2029
6.5.3 Germany Lacosamide Injection Market Size, 2018-2029
6.5.4 France Lacosamide Injection Market Size, 2018-2029
6.5.5 U.K. Lacosamide Injection Market Size, 2018-2029
6.5.6 Italy Lacosamide Injection Market Size, 2018-2029
6.5.7 Russia Lacosamide Injection Market Size, 2018-2029
6.5.8 Nordic Countries Lacosamide Injection Market Size, 2018-2029
6.5.9 Benelux Lacosamide Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Lacosamide Injection Revenue, 2018-2029
6.6.2 By Region – Asia Lacosamide Injection Sales, 2018-2029
6.6.3 China Lacosamide Injection Market Size, 2018-2029
6.6.4 Japan Lacosamide Injection Market Size, 2018-2029
6.6.5 South Korea Lacosamide Injection Market Size, 2018-2029
6.6.6 Southeast Asia Lacosamide Injection Market Size, 2018-2029
6.6.7 India Lacosamide Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Lacosamide Injection Revenue, 2018-2029
6.7.2 By Country – South America Lacosamide Injection Sales, 2018-2029
6.7.3 Brazil Lacosamide Injection Market Size, 2018-2029
6.7.4 Argentina Lacosamide Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Lacosamide Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Lacosamide Injection Sales, 2018-2029
6.8.3 Turkey Lacosamide Injection Market Size, 2018-2029
6.8.4 Israel Lacosamide Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Lacosamide Injection Market Size, 2018-2029
6.8.6 UAE Lacosamide Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Shijiazhuang No.4 Pharmaceutical Co., Ltd.
7.1.1 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Company Summary
7.1.2 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Business Overview
7.1.3 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Major Product Offerings
7.1.4 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Sales and Revenue in Global (2018-2023)
7.1.5 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Key News & Latest Developments
7.2 Chengdu Lier Pharmaceutical Co., Ltd.
7.2.1 Chengdu Lier Pharmaceutical Co., Ltd. Company Summary
7.2.2 Chengdu Lier Pharmaceutical Co., Ltd. Business Overview
7.2.3 Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Major Product Offerings
7.2.4 Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Sales and Revenue in Global (2018-2023)
7.2.5 Chengdu Lier Pharmaceutical Co., Ltd. Key News & Latest Developments
7.3 Hefei Yifan Biopharmaceuticals Inc.
7.3.1 Hefei Yifan Biopharmaceuticals Inc. Company Summary
7.3.2 Hefei Yifan Biopharmaceuticals Inc. Business Overview
7.3.3 Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Major Product Offerings
7.3.4 Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Sales and Revenue in Global (2018-2023)
7.3.5 Hefei Yifan Biopharmaceuticals Inc. Key News & Latest Developments
7.4 Jiangsu Haian Pharmaceutical Co., Ltd.
7.4.1 Jiangsu Haian Pharmaceutical Co., Ltd. Company Summary
7.4.2 Jiangsu Haian Pharmaceutical Co., Ltd. Business Overview
7.4.3 Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Major Product Offerings
7.4.4 Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Sales and Revenue in Global (2018-2023)
7.4.5 Jiangsu Haian Pharmaceutical Co., Ltd. Key News & Latest Developments
7.5 Jiangxi Kerui Pharmaceutical Co., Ltd.
7.5.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Company Summary
7.5.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Business Overview
7.5.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Major Product Offerings
7.5.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Sales and Revenue in Global (2018-2023)
7.5.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Key News & Latest Developments
7.6 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
7.6.1 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Summary
7.6.2 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Business Overview
7.6.3 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Major Product Offerings
7.6.4 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Sales and Revenue in Global (2018-2023)
7.6.5 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Key News & Latest Developments
7.7 UCB Pharma Limited
7.7.1 UCB Pharma Limited Company Summary
7.7.2 UCB Pharma Limited Business Overview
7.7.3 UCB Pharma Limited Lacosamide Injection Major Product Offerings
7.7.4 UCB Pharma Limited Lacosamide Injection Sales and Revenue in Global (2018-2023)
7.7.5 UCB Pharma Limited Key News & Latest Developments
7.8 Camber Pharmaceuticals
7.8.1 Camber Pharmaceuticals Company Summary
7.8.2 Camber Pharmaceuticals Business Overview
7.8.3 Camber Pharmaceuticals Lacosamide Injection Major Product Offerings
7.8.4 Camber Pharmaceuticals Lacosamide Injection Sales and Revenue in Global (2018-2023)
7.8.5 Camber Pharmaceuticals Key News & Latest Developments
7.9 Fresenius Kabi
7.9.1 Fresenius Kabi Company Summary
7.9.2 Fresenius Kabi Business Overview
7.9.3 Fresenius Kabi Lacosamide Injection Major Product Offerings
7.9.4 Fresenius Kabi Lacosamide Injection Sales and Revenue in Global (2018-2023)
7.9.5 Fresenius Kabi Key News & Latest Developments
8 Global Lacosamide Injection Production Capacity, Analysis
8.1 Global Lacosamide Injection Production Capacity, 2018-2029
8.2 Lacosamide Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Lacosamide Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Lacosamide Injection Supply Chain Analysis
10.1 Lacosamide Injection Industry Value Chain
10.2 Lacosamide Injection Upstream Market
10.3 Lacosamide Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lacosamide Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
